The effect of dexmedetomidine added to preemptive ropivacaine infiltration on post-operative pain after inguinal herniorrhaphy: a prospective, randomized, double-blind, placebo-controlled study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, H. | - |
dc.date.available | 2019-03-09T02:56:44Z | - |
dc.date.issued | 2012-08 | - |
dc.identifier.issn | 1682-8631 | - |
dc.identifier.issn | 1682-4016 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/15228 | - |
dc.description.abstract | BACKGROUND: Inguinal herniorrhaphy is frequently associated with persistent postoperative discomfort and pain. In this study, we evaluated the efficacy of dexmedetomidine added to preemptive ropivacaine infiltration in patients undergoing inguinal herniorrhaphy. METHODS: Fifty-two male patients were randomly assigned to two groups: group RO (n = 26) received 10 ml of 0.2% ropivacaine and group RD received 10 ml of 0.2% ropivacaine with 1 A mu g/kg dexmedetomidine, both applied via local wound infiltration 2 min prior to skin incision. Postoperatively, visual analogue scale pain score (VAS), fentanyl consumption, the frequency at which the patients pushed the button of the patient-controlled analgesia system (FPB), patient satisfaction, and the incidence of side effects were determined and recorded. RESULTS: The visual analogue scale pain scores were significantly lower until 24 hours after surgery, and fentanyl consumption and the FPB were significantly lower in Group RD until postoperative 12 hours compared with that of Group RO. The total amount of fentanyl consumption and the total FPB were significantly lower in Group RD as compared with Group RO. No significant differences were detected between groups in terms of nausea, vomiting, dizziness, drowsiness, constipation, and urinary retention. CONCLUSIONS: We conclude that dexmedetomidine added to preemptive ropivacaine infiltration reduces pain during the postoperative period after inguinal herniorrhaphy. Additionally, it is easy to administer, and has no adverse effects. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPRINGER WIEN | - |
dc.title | The effect of dexmedetomidine added to preemptive ropivacaine infiltration on post-operative pain after inguinal herniorrhaphy: a prospective, randomized, double-blind, placebo-controlled study | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s10353-012-0085-8 | - |
dc.identifier.bibliographicCitation | EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, v.44, no.4, pp 274 - 280 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000308647400011 | - |
dc.identifier.scopusid | 2-s2.0-84870439824 | - |
dc.citation.endPage | 280 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 274 | - |
dc.citation.title | EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA | - |
dc.citation.volume | 44 | - |
dc.type.docType | Article | - |
dc.publisher.location | 오스트리아 | - |
dc.subject.keywordAuthor | Dexmedetomidine | - |
dc.subject.keywordAuthor | infiltration | - |
dc.subject.keywordAuthor | inguinal herniorrhaphy | - |
dc.subject.keywordAuthor | postoperative pain | - |
dc.subject.keywordAuthor | ropivacaine | - |
dc.subject.keywordPlus | HERNIA REPAIR | - |
dc.subject.keywordPlus | REGIONAL ANESTHESIA | - |
dc.subject.keywordPlus | CAUDAL BLOCK | - |
dc.subject.keywordPlus | NERVE BLOCK | - |
dc.subject.keywordPlus | ANALGESIA | - |
dc.subject.keywordPlus | SURGERY | - |
dc.subject.keywordPlus | CLONIDINE | - |
dc.subject.keywordPlus | LIDOCAINE | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordPlus | KETOROLAC | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.